Pharmacogenomics: the promise of personalized medicine.
作者信息
Hood Ernie
出版信息
Environ Health Perspect. 2003 Aug;111(11):A581-9. doi: 10.1289/ehp.111-1241640.
Abstract
摘要
相似文献
1
Pharmacogenomics: the promise of personalized medicine.药物基因组学：个性化医疗的前景。
Environ Health Perspect. 2003 Aug;111(11):A581-9. doi: 10.1289/ehp.111-1241640.
2
Molecular diagnostics and personalized medicine. IBC Life Sciences Conference on Pharmacogenomics, June 24-25, 2003, London, UK.分子诊断与个性化医疗。2003年6月24 - 25日于英国伦敦举行的IBC生命科学药物基因组学会议。
Pharmacogenomics. 2003 Sep;4(5):541-5. doi: 10.1517/phgs.4.5.541.23796.
3
Implications of pharmacogenomics for drug development and clinical practice.药物基因组学对药物研发及临床实践的影响。
Arch Intern Med. 2005 Nov 14;165(20):2331-6. doi: 10.1001/archinte.165.20.2331.
4
Personalized medicine.个性化医疗。
Curr Opin Mol Ther. 2002 Dec;4(6):548-58.
5
Assessing patient readiness for the clinical adoption of personalized medicine.评估患者对临床采用个性化医疗的准备情况。
Public Health Genomics. 2009;12(3):163-9. doi: 10.1159/000189629. Epub 2009 Feb 10.
6
The conundrum of personalized cancer management, drug development, and economics.
Cancer Biother Radiopharm. 2007 Dec;22(6):719-21. doi: 10.1089/cbr.2007.500.
7
Personalized medicine: challenges in assessing and capturing value in the commercial environment.个性化医疗：在商业环境中评估和获取价值的挑战。
Expert Rev Mol Diagn. 2006 Mar;6(2):129-31. doi: 10.1586/14737159.6.2.129.
8
The microeconomics of personalized medicine: today's challenge and tomorrow's promise.个性化医疗的微观经济学：当今的挑战与明日的前景。
Nat Rev Drug Discov. 2009 Apr;8(4):279-86. doi: 10.1038/nrd2825. Epub 2009 Mar 20.
9
Getting to personalized cancer medicine: taking out the garbage.迈向个性化癌症医学：清除障碍。
Cancer. 2007 Oct 15;110(8):1641-3. doi: 10.1002/cncr.22966.
10
Personalized medicine prompts push to redesign clinical trials.
Nat Med. 2005 May;11(5):462. doi: 10.1038/nm0505-462a.
引用本文的文献
1
3D printing processes in precise drug delivery for personalized medicine.3D 打印在精准药物输送中的应用——个性化医疗的新途径。
Biofabrication. 2024 Apr 17;16(3). doi: 10.1088/1758-5090/ad3a14.
2
COVID19 Drug Repository: text-mining the literature in search of putative COVID19 therapeutics.COVID19 药物库：从文献中挖掘文本以寻找潜在的 COVID19 疗法。
Nucleic Acids Res. 2021 Jan 8;49(D1):D1113-D1121. doi: 10.1093/nar/gkaa969.
3
Building sophisticated sensors of extracellular cues that enable mammalian cells to work as "doctors" in the body.构建复杂的细胞外线索传感器，使哺乳动物细胞能够在体内充当“医生”。
Cell Mol Life Sci. 2020 Sep;77(18):3567-3581. doi: 10.1007/s00018-020-03486-y. Epub 2020 Mar 17.
4
Model-Based Individualized Treatment of Chemotherapeutics: Bayesian Population Modeling and Dose Optimization.基于模型的化疗药物个体化治疗：贝叶斯群体建模与剂量优化。
PLoS One. 2015 Jul 30;10(7):e0133244. doi: 10.1371/journal.pone.0133244. eCollection 2015.
5
Revitalizing personalized medicine: respecting biomolecular complexities beyond gene expression.重振个性化医学：超越基因表达，尊重生物分子复杂性。
CPT Pharmacometrics Syst Pharmacol. 2014 Apr 16;3(4):e110. doi: 10.1038/psp.2014.6.
6
Personalized medicine: is it a pharmacogenetic mirage?个体化医学：这是一个药物遗传学的幻象吗？
Br J Clin Pharmacol. 2012 Oct;74(4):698-721. doi: 10.1111/j.1365-2125.2012.04328.x.
7
Simultaneous clustering of gene expression data with clinical chemistry and pathological evaluations reveals phenotypic prototypes.基因表达数据与临床化学和病理评估的同时聚类揭示了表型原型。
BMC Syst Biol. 2007 Feb 23;1:15. doi: 10.1186/1752-0509-1-15.
8
Ushering in the new toxicology: toxicogenomics and the public interest.迎来新毒理学：毒理基因组学与公共利益。
Environ Health Perspect. 2005 Jul;113(7):818-22. doi: 10.1289/ehp.7732.
Zotero 插件